![Robert Woods](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Woods
Directeur des opérations chez
SCHOLAR ROCK HOLDING CORPORATION
Fortune : 2 M $ au 31/05/2026
Profil
Actuellement, R. Keith Woods occupe le poste de directeur de l'exploitation d'argenx SE. Dans sa carrière antérieure, il a occupé le poste de SVP-North American Operations chez Alexion Pharmaceuticals, Inc. et de vice-président et directeur général chez Alexion Pharma UK Ltd. (une filiale d'Alexion Pharmaceuticals, Inc.). Il est titulaire d'un diplôme de premier cycle de la Florida State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 48 034 ( 0,04% ) | 2 M $ | 31/05/2026 | |
| 09/06/2025 | 6 000 ( 0,01% ) | 25 860 $ | 31/05/2026 | |
-.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Robert Woods
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/12/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur des opérations | 27/04/2025 |
Anciens postes connus de Robert Woods
| Sociétés | Poste | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 22/08/2025 |
| ROCKET PHARMACEUTICALS, INC. | Directeur des opérations | 18/06/2025 |
| ARGENX SE | Corporate Officer/Principal | 01/06/2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Robert Woods
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
